AAD: Long-Term Improvement Seen With Ruxolitinib in Vitiligo

TUESDAY, March 28, 2023 -- For patients with nonsegmental vitiligo, continued improvement in seen during a long-term extension of ruxolitinib treatment, according to study presented at the annual meeting of the American Academy of Dermatology, held...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news